News & Features

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Mindfulness training shows promise for people with MS

May 20, 2020

One of the reasons that mindfulness training is so promising is because it is an easily accessible treatment for all patients.
Learn more

Animal study shows human brain cells repair damage in MS

May 20, 2020

Study provides one of the final pieces of evidence necessary to advance treatment strategy to clinical trials.
Learn more

Study: Local inflammatory cells are characteristic for advanced MS

May 18, 2020

These new findings support the idea that during the late phase of MS, the disease is happening entirely inside the brain.
Learn more

FDA approves of Bafiertam for MS 

May 04, 2020

Bafiertam is a prescription medicine used to treat relapsing forms of MS.
Learn more

MS Focus at Sea to set sail in 2021

April 27, 2020

We will be exploring the eastern Caribbean on board Celebrity Cruise Line’s Celebrity Apex.
Learn more

Monocytes may play key role in myelin damage

April 24, 2020

If true, in the future most forms of MS could be treated by specifically deactivating monocytes.
Learn more

Ocrevus (ocrelizumab) shorter infusion time application accepted

April 23, 2020

The FDA is expected to make a decision on the application by the end of 2020.
Learn more

Researchers seek participants for health, wellness study

April 21, 2020

Study seeks to understand how individuals look for health and wellness information online in their day-to-day activities.
Learn more

Researchers seek participants for work life and MS study

April 20, 2020

They are investigating links between the perceived severity of MS symptoms and the perception the work environment and work outcomes.
Learn more

Mindfulness training shows promise for people with MS

May 20, 2020

One of the reasons that mindfulness training is so promising is because it is an easily accessible treatment for all patients.
Learn more

Animal study shows human brain cells repair damage in MS

May 20, 2020

Study provides one of the final pieces of evidence necessary to advance treatment strategy to clinical trials.
Learn more

Study: Local inflammatory cells are characteristic for advanced MS

May 18, 2020

These new findings support the idea that during the late phase of MS, the disease is happening entirely inside the brain.
Learn more

FDA approves of Bafiertam for MS 

May 04, 2020

Bafiertam is a prescription medicine used to treat relapsing forms of MS.
Learn more

MS Focus at Sea to set sail in 2021

April 27, 2020

We will be exploring the eastern Caribbean on board Celebrity Cruise Line’s Celebrity Apex.
Learn more

Monocytes may play key role in myelin damage

April 24, 2020

If true, in the future most forms of MS could be treated by specifically deactivating monocytes.
Learn more

Ocrevus (ocrelizumab) shorter infusion time application accepted

April 23, 2020

The FDA is expected to make a decision on the application by the end of 2020.
Learn more

Researchers seek participants for health, wellness study

April 21, 2020

Study seeks to understand how individuals look for health and wellness information online in their day-to-day activities.
Learn more

Researchers seek participants for work life and MS study

April 20, 2020

They are investigating links between the perceived severity of MS symptoms and the perception the work environment and work outcomes.
Learn more

MS groups launch coronavirus and MS reporting database

April 10, 2020

This effort will capture information on outcomes of people with MS who have developed COVID-19.
Learn more

Compound in fruit peels halts damage, spurs neuronal repair in MS

April 09, 2020

The study’s authors said the next steps for their investigations include testing the compound for safety.
Learn more

Bristol Myers Squibb expands patient support programs

April 07, 2020

The program features immediate access for patients who have lost their employment and health insurance.
Learn more

iConquerMS seeks participants for COVID-19 study

April 03, 2020

The study is open to everyone, whether or not they have been diagnosed with, exposed to, or have symptoms of COVID-19.
Learn more

FDA approves Zeposia, a new oral treatment for relapsing MS

March 26, 2020

In clinical trials, Zeposia demonstrated efficacy on a key clinical marker of disease activity – annualized relapse rate – as compared to Avonex.
Learn more

A Message From Our Executive Director

March 19, 2020

A message from our Executive Director regarding COVID-19 (coronavirus) pandemic response.
Learn more

VR shows promise for early detection of MS balance problems

March 13, 2020

Researchers thought the MS subjects with balance impairments would differ clearly from normal subjects in these corrective reactions.
Learn more

Study: Diet has an effect on the MS disease course

March 12, 2020

Initial MRI studies showed propionic acid may reduce brain atrophy as a sign of neuronal cell death. 
Learn more

MS and coronavirus – What do you need to know?

March 06, 2020

If you have symptoms suspicious for COVID-19 infection, have traveled to a high risk area, or have been in close proximity to a person who meets one of those two criteria, please call your MS provider for further instructions.
Learn more


Show More News